Join us Dec. 1-3 in Nashville for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Amid growing tension over workplace AI, agencies have a window to reimagine staffing
AI agents are becoming common among agencies, but most companies haven’t grasped their potential to reshape teams.
From Celsius to Maybelline, more brands are lining up for the NYC Marathon’s 50th anniversary
The brands showing up at the annual race represent a more diverse cross-section of retail than ever before.
Future of Marketing Briefing: SharkNinja’s McLaren deal treats F1 fandom as the asset
What SharkNinja;s McLaren deal says about the new price of F1 fandom.